Nicotine Replacement Therapy

Integrated care involving medication and intensive counseling showed effectiveness for smoking cessation among adults undergoing screening for lung cancer, the results of a randomized clinical trial showed.

Healio Pulmonology has compiled the top news on smoking and vaping posted in 2024.

The FDA has cleared an investigational new drug application for the RespiRx Nicotine Inhaler (QN-01), an inhaled nicotine replacement therapy, according to a press release.

BOSTON — Smokers with asthma were more likely to be prescribed a smoking cessation treatment than smokers who did not have asthma, according to a poster at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Studies on the risk for maternal, fetal and infant outcomes with exclusive vaping, smoking or nonuse during pregnancy have contradictory and unreliable conclusions with poor study quality, according to a systematic review.

Individuals using nicotine e-cigarettes have a higher likelihood of quitting smoking compared with nicotine replacement therapy users, according to data published in Cochrane Database of Systematic Reviews.

Among various smoking cessation therapies, the highest likelihood for quitting was found with use of e-cigarettes, varenicline or cytisine, according to results published in Cochrane Database of Systematic Reviews.

Hospitalized smokers who received varenicline plus nicotine replacement therapy lozenges had an increased likelihood for abstinence, according to a presentation at the European Respiratory Society International Congress.

Prescription medications added onto tobacco longitudinal care did not improve long-term abstinence rates among current smokers eligible for lung cancer screening, according to results published in JAMA Network Open.

Although a recent report from the CDC showed that cigarette smoking in 2021 is the lowest it has been since 1965, millions of people continue to smoke, with many struggling to quit with the current authorized treatments.